{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:53:24Z","timestamp":1790963604866,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20lm0203140"],"award-info":[{"award-number":["JP20lm0203140"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18ck0106416"],"award-info":[{"award-number":["JP18ck0106416"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.omto.2021.06.008","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:00:22Z","timestamp":1624525222000},"page":"388-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Oncolytic herpes virus G47\u0394 injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis"],"prefix":"10.1016","volume":"22","author":[{"given":"Toshihiro","family":"Uchihashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwako","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Sugauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikihiko","family":"Kogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Todo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2021.06.008_bib1","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omto.2021.06.008_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11912-007-0012-5","article-title":"Occult primary head and neck carcinoma","volume":"9","author":"Schmalbach","year":"2007","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.omto.2021.06.008_bib3","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/cncr.25834","article-title":"Nodal yield and survival in oral squamous cancer: Defining the standard of care","volume":"117","author":"Ebrahimi","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.omto.2021.06.008_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9610(02)01378-8","article-title":"Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas","volume":"185","author":"Shingaki","year":"2003","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.omto.2021.06.008_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.otohns.2005.09.025","article-title":"Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth","volume":"134","author":"Dias","year":"2006","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.omto.2021.06.008_bib6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMra001375","article-title":"Head and neck cancer","volume":"345","author":"Forastiere","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omto.2021.06.008_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hed.10257","article-title":"Functional anatomy of the upper aerodigestive tract\u2019s lymphatic drainage system and its role in metastasis of squamous cell carcinoma","volume":"25","author":"Werner","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.omto.2021.06.008_bib8","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1038\/sj.onc.1209037","article-title":"Oncolytic viral therapies - the clinical experience","volume":"24","author":"Aghi","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2021.06.008_bib9","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1158\/1078-0432.CCR-15-2709","article-title":"Talimogene Laherparepvec for the treatment of advanced melanoma","volume":"22","author":"Ott","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib10","doi-asserted-by":"crossref","first-page":"e1115641","DOI":"10.1080\/2162402X.2015.1115641","article-title":"First oncolytic virus approved for melanoma immunotherapy","volume":"5","author":"Pol","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omto.2021.06.008_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/21645515.2017.1412896","article-title":"Talimogene laherparepvec: First in class oncolytic virotherapy","volume":"14","author":"Conry","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omto.2021.06.008_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-016-0158-5","article-title":"Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy","volume":"4","author":"Rehman","year":"2016","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omto.2021.06.008_bib13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/hed.20840","article-title":"Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma","volume":"30","author":"Mace","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.omto.2021.06.008_bib14","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1158\/1078-0432.CCR-06-0759","article-title":"A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor","volume":"12","author":"Hu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib15","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-10-0196","article-title":"Phase I\/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III\/IV squamous cell cancer of the head and neck","volume":"16","author":"Harrington","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib16","first-page":"798","article-title":"A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer","volume":"6","author":"Ganly","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib17","first-page":"6359","article-title":"Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial","volume":"60","author":"Nemunaitis","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib18","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1200\/JCO.2003.03.544","article-title":"An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia","volume":"21","author":"Rudin","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2021.06.008_bib19","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2002.08.042","article-title":"Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers","volume":"20","author":"Pecora","year":"2002","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2021.06.008_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1089\/104303402320138998","article-title":"Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases","volume":"13","author":"Wong","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2021.06.008_bib21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nm1404","article-title":"In\u00a0vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus","volume":"12","author":"Kishimoto","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omto.2021.06.008_bib22","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1158\/1078-0432.CCR-08-2690","article-title":"Telomerase-specific virotheranostics for human head and neck cancer","volume":"15","author":"Kurihara","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib23","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1535-7163.MCT-18-1372","article-title":"Sentinel lymph node-targeted therapy by oncolytic sendai virus suppresses micrometastasis of head and neck squamous cell carcinoma in an orthotopic nude mouse model","volume":"18","author":"Tanaka","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omto.2021.06.008_bib24","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1073\/pnas.101136398","article-title":"Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing","volume":"98","author":"Todo","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2021.06.008_bib25","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1128\/JVI.72.9.7005-7011.1998","article-title":"The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha","volume":"72","author":"Cassady","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2021.06.008_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/jvi.62.1.196-205.1988","article-title":"Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant","volume":"62","author":"Goldstein","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2021.06.008_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0092-8674(94)90215-1","article-title":"A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes","volume":"77","author":"York","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.omto.2021.06.008_bib28","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/JVI.75.11.5189-5196.2001","article-title":"A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals","volume":"75","author":"Mohr","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2021.06.008_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3892\/ijo.2012.1529","article-title":"Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma","volume":"41","author":"Morita","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omto.2021.06.008_bib30","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1073\/pnas.84.12.4205","article-title":"Functional characterization of an antigen involved in an early step of T-cell activation","volume":"84","author":"Cosulich","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2021.06.008_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.oraloncology.2017.07.005","article-title":"The importance of log odds of positive lymph nodes for locoregional recurrence in oral squamous cell carcinoma","volume":"72","author":"Safi","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.omto.2021.06.008_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa1506007","article-title":"Elective versus therapeutic neck dissection in node-negative oral cancer","volume":"373","author":"D\u2019Cruz","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omto.2021.06.008_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-9610(69)90207-4","article-title":"Role of the cervical lymph nodes as a barrier to metastatic tumor","volume":"118","author":"Baker","year":"1969","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.omto.2021.06.008_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/mt.2013.215","article-title":"Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity","volume":"22","author":"Granot","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2021.06.008_bib35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1470-2045(06)70975-5","article-title":"Immunobiology of the sentinel lymph node and its potential role for antitumour immunity","volume":"7","author":"Kim","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omto.2021.06.008_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri701","article-title":"The enemy within: keeping self-reactive T\u00a0cells at bay in the periphery","volume":"2","author":"Walker","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omto.2021.06.008_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T\u00a0cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2021.06.008_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mt.2010.264","article-title":"Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy","volume":"19","author":"Sobol","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2021.06.008_bib39","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/cas.14388","article-title":"Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma","volume":"111","author":"Koike","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omto.2021.06.008_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.omto.2020.08.010","article-title":"Neoadjuvant use of oncolytic herpes virus G47\u0394 enhances the antitumor efficacy of radiofrequency ablation","volume":"18","author":"Yamada","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omto.2021.06.008_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2017.07.006","article-title":"Macrophage polarization contributes to glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade","volume":"32","author":"Saha","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2021.06.008_bib42","first-page":"153","article-title":"In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity","volume":"61","author":"Todo","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib43","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm0995-938","article-title":"Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas","volume":"1","author":"Mineta","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.omto.2021.06.008_bib44","first-page":"222","article-title":"Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma","volume":"4","author":"Miyatake","year":"1997","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omto.2021.06.008_bib45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/1078-0432.CCR-05-1494","article-title":"Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy","volume":"12","author":"Ino","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib46","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1158\/1078-0432.CCR-05-1090","article-title":"Oncolytic herpes simplex virus vector g47delta in combination with androgen ablation for the treatment of human prostate adenocarcinoma","volume":"11","author":"Fukuhara","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.06.008_bib47","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1089\/10430349950016483","article-title":"Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus","volume":"10","author":"Todo","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2021.06.008_bib48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ijc.24065","article-title":"SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion","volume":"124","author":"Tanaka","year":"2009","journal-title":"Int. J. Cancer"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770521000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770521000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:34:47Z","timestamp":1778880887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770521000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":48,"alternative-id":["S2372770521000887"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2021.06.008","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic herpes virus G47\u0394 injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2021.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}